EMD Millipore: Repeat(Ab)le – Epigenetics Antibodies
We offer an extensive, focused portfolio of antibodies and immunoassays, including validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins…
EMD Millipore has developed technology that addresses three pivotal areas of epigenetics research that are playing substantial roles in the control of epigenetic gene expression and inheritance: DNA methylation, histone modification, and—more recently—RNA-associated gene silencing events and modification, now called RNA epigenetics. We offer an extensive, focused portfolio of antibodies and immunoassays, including validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins.
Downloads
Feature: Repeat(Ab)le Epigenetics Antibodies
Learn More
Click here to find out more about epigenetics antibodies
Related content from this organisation
- Biotech leader champions targeted cancer treatments and diversity
- Product hub: Light the path to your next neuroscience discovery with a new ultrasensitive NF-L immunoassay
- A high-throughput macrodomain assay to identify coronavirus drugs
- Building a powerful portfolio of sepsis biomarker signatures for therapeutic clinical trials
- Drug Target Review Assays ebook 2022
Related topics
Assays, Drug Discovery Processes, Drug Targets, Screening, Stem Cells, Translational Science
Related organisations
Merck KGaA
